In human LN, the contribution of the alternative complement pathway to the development of kidney damage is supported by the observation that reduction in C3, but not C4, is associated with LN flare, and with the development of circulating anti-C3b antibodies [27,32]. Here, C4A is linked to lobular neoplasia.